Center for Virtual Care Value and Equity (ViVE)
虚拟护理价值和公平中心 (ViVE)
基本信息
- 批准号:10621602
- 负责人:
- 金额:$ 76.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAccelerationAddressAdministratorAdoptionAmericanCOVID-19 pandemicCaringClinicalClinical ResearchClinical SciencesComplexConsensusConsultCost SavingsCountryDataData CollectionDedicationsDevelopmentDiseaseEducationEducational workshopEffectivenessEnsureEnvironmentEquitable healthcareEquityEthnic OriginEvaluationFee-for-Service PlansFoundationsFundingFutureGoalsHealthHealth Services AccessibilityHealth systemHealthcareHumanInfrastructureInstitutionInterviewInvestigationKnowledgeLearningMeasurementMeasuresModelingNatureNorth CarolinaOutcomePatientsPediatric ResearchPoliciesPolicy DevelopmentsPolicy MakerPopulationPositioning AttributeProductivityProgram SustainabilityProviderRaceResearchResearch PersonnelResearch SupportResourcesRiskRuralSeriesServicesSiteSocioeconomic StatusStructureTimeTrainingTranslational ResearchUnderserved PopulationUniversitiesVisionWorkWorkforce Developmentaccess disparitiescare costscare deliverycare seekingcare systemsdigital deliveryempowermentevidence baseexperiencegeographic barrierhealth care availabilityhealth care deliveryhealth care servicehealth disparityimplementation frameworkimplementation scienceimprovedinnovationinstrumentparitypaymentpopulation healthpreventable deathprogramsresearch studyresearch to practiceskillssocioeconomicssuccesstelehealthtoolunderserved areavirtual healthcarevirtual worldwebinar
项目摘要
Abstract
Importance: Despite the emergence of virtual care (VC) programs during the COVID-19 pandemic, the
sustainability of these programs is unknown because of concerns relating to health access disparities, future
payment parity, effective integration into clinical workflows, and the misalignment of many of the goals of VC
integration with a fee-for-service payment environment. Lack of access to Real-World VC Data and knowledge
of the unique needs of different VC stakeholder groups exacerbates health disparities and can impede
attaining financial sustainability. Similarly, there is no consensus on evidence-based research measurements
specific to VC, which hinders the effectiveness and sustainability of VC
Objective: Lay strong foundation for future adoption and dissemination of VC research capabilities.
Specific aims: (1) Build and promote a productive coalition of internal and external resources, thought leaders
and stakeholder representatives to enable the use of Real-World VC Data and to generate innovative and
pragmatic approaches to advance scalable equity and value in VC both locally and nationally.
(2) Assess the facilitators and barriers for key stakeholders to achieve equitable and sustainable VC by
conducting two rounds of semi-structured interviews.
(3) Develop and validate consensus around VC Equity and Value frameworks (e.g., outcome metrics) that will
accelerate future translational research and provide evidence-based guidance for VC service and policy.
(4) Train workforce to implement validated VC Equity and Value frameworks to improve human health.
Center Activities: ViVE will continuously grow by learning from conducting its research and supporting the
research of others. To the extent, ViVE will create new infrastructure and provide access to Real-World VC
Research Data and VC Expertise that will support and advance VC research. ViVE will assess the facilitators
and barriers to achieving equitable and sustainable VC from key stakeholders using semi-structured
interviews. Additionally, ViVE will shift the current status quo of VC research by building consensus around VC
equity and value frameworks. To ensure the effective implementation of these frameworks, ViVE will conduct
workforce training sessions to improve the knowledge and skills required to implement VC frameworks.
Expected outcomes: On successful completion of our research, we expect contributions to include (1)
accelerating NC TraCS (UNC CTSA) clinical and translational science by expediting the development of a VC
research hub, (2) developing a VC coalition that advances translational VC research by enabling researchers
to access Real-World VC Data, resources, and expertise, (3) building and validating VC measurement
approaches and outcomes metrics for equity and value, and (4) demonstrating real-world utility of validated
outcomes and measurements through implementation in clinical research studies.
Page 1 of 1
抽象的
重要性:尽管在 COVID-19 大流行期间出现了虚拟护理 (VC) 项目,但
由于对健康获取差异、未来的担忧等问题,这些计划的可持续性尚不清楚。
支付平价、有效融入临床工作流程以及风险投资的许多目标的不一致
与按服务付费的支付环境集成。无法获得真实世界的风险投资数据和知识
不同风险投资利益相关者群体的独特需求加剧了健康差异,并可能阻碍
实现财务可持续性。同样,基于证据的研究测量也没有达成共识
专门针对VC,这阻碍了VC的有效性和可持续性
目标:为未来采用和传播风险投资研究能力奠定坚实的基础。
具体目标:(1)建立和促进内部和外部资源、思想领袖的富有成效的联盟
和利益相关者代表,以实现真实世界风险投资数据的使用并产生创新和
采取务实的方法,在本地和全国范围内推进风险投资的可扩展公平性和价值。
(2) 评估关键利益相关者实现公平和可持续风险投资的促进因素和障碍:
进行两轮半结构化面试。
(3) 围绕风险投资股权和价值框架(例如结果指标)制定并验证共识,这将
加速未来的转化研究,为风险投资服务和政策提供循证指导。
(4) 培训员工实施经过验证的风险投资股权和价值框架,以改善人类健康。
中心活动:ViVE 将通过研究学习和支持来不断发展
他人的研究。在某种程度上,ViVE 将创建新的基础设施并提供对真实世界风险投资的访问
研究数据和风险投资专业知识将支持和推进风险投资研究。 ViVE 将评估协调员
主要利益相关者使用半结构化实现公平和可持续风险投资的障碍
采访。此外,ViVE将通过围绕风险投资建立共识来改变风险投资研究的现状
公平和价值框架。为了确保这些框架的有效实施,ViVE将进行
劳动力培训课程,以提高实施风险投资框架所需的知识和技能。
预期成果:成功完成我们的研究后,我们预计贡献包括 (1)
通过加快 VC 的开发,加速 NC TraCS (UNC CTSA) 临床和转化科学
研究中心,(2) 建立一个风险投资联盟,通过支持研究人员来推进转化风险投资研究
访问真实世界的风险投资数据、资源和专业知识,(3) 构建和验证风险投资衡量
公平和价值的方法和结果指标,以及(4)展示经过验证的现实世界效用
通过临床研究实施的结果和测量。
第 1 页,共 1 页
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Saif Khairat其他文献
Saif Khairat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Saif Khairat', 18)}}的其他基金
Improving Providers’ Decision-Making and Reducing Information Overload Using Information Visualization in Electronic Health Records
使用电子健康记录中的信息可视化改进提供商的决策并减少信息过载
- 批准号:
10400931 - 财政年份:2021
- 资助金额:
$ 76.12万 - 项目类别:
Improving Providers’ Decision-Making and Reducing Information Overload Using Information Visualization in Electronic Health Records
使用电子健康记录中的信息可视化改进提供商的决策并减少信息过载
- 批准号:
10180237 - 财政年份:2021
- 资助金额:
$ 76.12万 - 项目类别:
Improving Providers’ Decision-Making and Reducing Information Overload Using Information Visualization in Electronic Health Records
使用电子健康记录中的信息可视化改进提供商的决策并减少信息过载
- 批准号:
10560641 - 财政年份:2021
- 资助金额:
$ 76.12万 - 项目类别:
相似国自然基金
基于增广拉格朗日函数的加速分裂算法及其应用研究
- 批准号:12371300
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
肠菌源性丁酸上调IL-22促进肠干细胞增殖加速放射性肠损伤修复的机制研究
- 批准号:82304065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肌红蛋白构象及其氧化还原体系探究tt-DDE加速生鲜牛肉肉色劣变的分子机制
- 批准号:32372384
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于联邦学习自动超参调整的数据流通赋能加速研究
- 批准号:62302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
M2 TAMs分泌的OGT通过促进糖酵解过程加速肝细胞癌恶性生物学行为的机制研究
- 批准号:82360529
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Inspiratory Muscle Training to Improve Total Joint Arthroplasty Outcomes
吸气肌训练可改善全关节置换术的效果
- 批准号:
10725952 - 财政年份:2023
- 资助金额:
$ 76.12万 - 项目类别:
Optimizing the implementation of personalized risk-prediction models for venous thromboembolism among hospitalized adults
优化住院成人静脉血栓栓塞个性化风险预测模型的实施
- 批准号:
10658198 - 财政年份:2023
- 资助金额:
$ 76.12万 - 项目类别:
Learning Precision Medicine for Rare Diseases Empowered by Knowledge-driven Data Mining
通过知识驱动的数据挖掘学习罕见疾病的精准医学
- 批准号:
10732934 - 财政年份:2023
- 资助金额:
$ 76.12万 - 项目类别:
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
肌萎缩侧索硬化症自体杂交 TREG/Th2 细胞疗法 (RAPA-501) 的中型扩大试验
- 批准号:
10834469 - 财政年份:2023
- 资助金额:
$ 76.12万 - 项目类别: